MDCT Shows Potential for Detecting Bladder Cancer Without Surgery or Contrast

	Tweet

MDCT urography is a promising technique for detecting bladder tumors both with and without contrast material, helping patients avoid an invasive test, according to a new study by researchers from the University of Michigan Health System in Ann Arbor, MI.

For the study, 92 patients with bladder cancers were evaluated with MDCT. The researchers were able to identify 87 of the 92 bladder tumors on MDCT, regardless of whether the portion of the bladder was opacified with contrast material or not.

Usually, bladder cancer is detected by cystoscopy, an uncomfortable procedure in which an instrument is inserted into the urethra to sample or see inside the bladder. “Urologists often ask for MDCT to evaluate the ureters and kidneys for further disease. In doing so, we found that we saw most of the bladder cancers identified by cystoscopy on our MDCT, so we wondered if MDCT could be used to investigate the bladder on its own. Based on our study, it looks like this is a possibility,” said Jonathan Willatt, MD, lead author of the study.

In addition, the researchers found that it didn’t always matter whether contrast was used or not. “The problem with contrast material is that once it has passed from the ureters to the bladder it tends to opacify unevenly. When this happens, the doctors either roll the patient over repeatedly to mix the urine and contrast or administer a diuretic to get the patient to void and then allow the bladder to fill with contrast-enhanced urine. We found that we could see almost all of our tumors in the unopacified part,” said Dr. Willatt. “With new CT technology we can scan so rapidly that if we time it right, and if we get the bladder full enough, we feel that there is scope for evaluating the bladder fully with CT which may obviate the need for the more invasive and less comfortable cystoscopy,” he added.

The researchers also discovered that both CT and cystoscopy struggle with patients who have had previous bladder treatment such as surgery, radiotherapy or chemotherapy, so monitoring cancer recurrence is still a problem for both tests.

The full results of the study will be presented on Monday, May 1, 2006 during the American Roentgen Ray Society Annual Meeting in Vancouver, BC.

About ARRS
The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the U.S Radiologists from all over the world attend the ARRS Annual Meeting to take part in instructional courses, scientific paper presentations, symposiums, new issues forums and scientific and commercial exhibits related to the field of radiology. The ARRS is named after Wilhelm Ro"entgen, who discovered the x-ray in 1895.

RELATED STORIES:
Early menopause related to bladder cancer risk   Women in nursing homes often have bladder problems   Chemicals in meat may be linked to bladder cancer   Robotic Surgery Extends Benefits to Bladder Cancer Patients   Survivors of Childhood Cancers Treated with Cyclophosphamide More Likely to Develop Bladder Cancer   Delaying bladder cancer surgery increases mortality   Radiation does not improve survival for rare, invasive bladder cancer   New treatment option studied for bladder cancer   UT Southwestern researchers investigate high-risk populations for bladder-cancer screenings   Scientists find one reason why bladder cancer hits more men   Arsenic cancer risk still high decades later in Chile region   Retired firefighters could be at increased risk for developing bladder cancer   Meat, Especially If It’s Well Done, May Increase Risk of Bladder Cancer   Variation in prostate stem cell antigen gene raises bladder cancer risk   Bladder cancer: A difficult problem?   Estrogen use tied to bladder control problems   Cholesterol drug inhibits cancer cells in lab   Sales jobs tied to bladder cancer risk   Not enough evidence for bladder cancer screening   New Biomarker Test Could Predict Outcome for Bladder Cancer Patients   New Trial Targets Kidney Cancer Drug in Bladder Cancer   Brochure Helps Patients Understand Treatments for Bladder Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]